Navigation Links
Therapure Biopharma Inc. Announces Manufacturing Agreement with Biomedical Frontiers Incorporated -- Contract will Support Phase II Trials for Thalassemia Treatment
Date:11/28/2008

Thomas Wellner, President and CEO of Therapure Biopharma Inc. today announced that the Company has signed a biomanufacturing services agreement with Minnesota-based Biomedical Frontiers Incorporated for the production of an iron chelating agent used in the treatment of thalassemia, an inherited blood disorder.

Toronto, ON (PRWEB) November 28, 2008 - Thomas Wellner, President and CEO of Therapure Biopharma Inc. today announced that the Company has signed a biomanufacturing services agreement with Minnesota-based Biomedical Frontiers Incorporated for the production of an iron chelating agent used in the treatment of thalassemia, an inherited blood disorder.

Therapure Biopharma will apply experience gained previously in the production of Biomedical Frontiers' deferoxamine conjugates, which are injectable iron-binding drugs used to neutralize iron build-up in the blood of patients with an iron overload disorder. Biomedical Frontiers believes that their product offers advantages over existing treatments for thalassemia that will result in improved patient compliance and therefore better clinical outcomes.

In addition to manufacturing clinical trial supplies, Therapure Biopharma will provide debt financing that will partially support Biomedical Frontiers' Phase II clinical program for the product. The contract also gives Therapure Biopharma long-term commercial manufacturing rights when the product is approved by regulators.

"Production of this compound for Biomedical Frontiers is a great example of the flexibility of our modern biomanufacturing facility," said Thomas Wellner. "We are able to produce the necessary supplies of their compound quickly to support the continuing clinical development of this important new product."

"We previously contracted with Therapure Biopharma in the manufacture of drug material to support our successful devel
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Therapure Biopharma Inc. opens for business with first client contracts
2. Therapure Biopharma Inc. announces collaboration with Induce Biologics Inc.
3. Therapure Biopharma Inc. announces collaboration with BioVectra Inc.
4. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
6. PDL BioPharma Announces Internal CEO Investigation Found No Credible Evidence of Improper Personal Conduct or Breach of Fiduciary Duty
7. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
8. PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development
9. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
10. XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
11. Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)..., Mass., Nov. 6 Myriant Technologi...loper and manufacturer of renewable bio-chemicals...chnology provider Uhde GmbH, one of the world,s le...nounced an alliance for the engineering, procureme...Succinic Acid plants based on renewable feedstocks...
(Date:11/6/2009)...D, Calif., Nov. 6 Intarcia Therape...ts ITCA 650 (DUROS® continuous delivery of ex...tes at the Ninth Annual Diabetes Technology Meetin...ewscom.com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,... Via ITCA 650 Lowers Plasma Glucose, HbA1c and Red...
(Date:11/5/2009)...PANY, N.J., Nov. 5 DSM Pharmaceuti...nufacturing alliance with Galenix, Saint Jean D,Il...rcial scale manufacturing partner for Galenix comm...alenix will collaborate on business development op...hnologies, based on the strength of Galenix in dru...
(Date:11/5/2009)...OK, N.Y., Nov. 5 BioSpec...armaceutical company developing first-in-class col...cial results for the third quarter ended September...n September of this year, the FDA,s Arthritis Advi...of 12-0, the approval of XIAFLEX(TM) for the treat...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5
...n. Remember that word? It was as popular in Web ci...tain vendor circles. The long and short of it was ...nd let suppliers sell directly to consumers, eithe... loop would take a slice of the middle-mans cut, s...sumers. A real win-win situation as long as you di...
...ic stem-cell research, policymakers and investors ... answer is no. But among those states poised to co...onsin may be the best positioned for success. , ,T... Gov. Jim Doyle is not aimed at advancing stem-cel...sciences that may yield advances across a much bro...
...ike the roads and all the highways. Somehow there ... some drive taxis, others drive Ferraris orrace tr... and so are the maps. Thank heaven. , ,This brings...nternet ever so underutilized and why is 90 percen...s it because this highway is considered free and t...
Other Biology Technology:A funny thing happened on the way out of the back office 2A funny thing happened on the way out of the back office 3Life-science research plan is about more than stem cells 2Life-science research plan is about more than stem cells 3Global Internet branding of technology companies 2Global Internet branding of technology companies 3
(Date:11/6/2009)...lly live in harmony with their arboreal hosts. But...pace in their trees of choice, the ants can get de...published in the November issue of the American N...e into live trees, and it reopens a centuries-old .... , Ants and certain species of plants and trees...
(Date:11/5/2009)...of Biology Teachers (NABT) will recognize Leonard ...Naugatuck Valley Community College (NVCC) in Water...on Award during the NABT annual professional devel...n Denver, Colorado. , The Evolution Education Aw...ological Sciences,(AIBS) and Biological Sciences ...
(Date:11/4/2009)...ientists are reluctant to officially endorse green...nues to grow about its protective effects, includi...vention Research , a journal of the American Assoc...duction in oral cancer. , Vassiliki Papadimitra...ment of Thoracic/Head and Neck Medical Oncology at...
Breaking Biology News(10 mins):Ants are friendly to some trees, but not others 2Biologists, educators recognize excellence in evolution education 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2Scholar unconvinced new lie detection methods better than old ones 8689 1Scholar unconvinced new lie detection methods better than old ones 8689 2Scholar unconvinced new lie detection methods better than old ones 8689 3Scholar unconvinced new lie detection methods better than old ones 8689 4ClearTrial to Chair Session at DIA 45th Annual Meeting on 26quot 3BEffective Operational Planning for Adaptive Clinical Trials 26quot 3B 12415 1ClearTrial to Chair Session at DIA 45th Annual Meeting on 26quot 3BEffective Operational Planning for Adaptive Clinical Trials 26quot 3B 12415 2ClearTrial to Chair Session at DIA 45th Annual Meeting on 26quot 3BEffective Operational Planning for Adaptive Clinical Trials 26quot 3B 12415 3Kashi Company Debuts Heart to Heart 28TM 29 Whole Grain Crackers 47606 1Kashi Company Debuts Heart to Heart 28TM 29 Whole Grain Crackers 47606 2Kashi Company Debuts Heart to Heart 28TM 29 Whole Grain Crackers 47606 3
...TC Bulletin Board: STIY), a leader in electro-stun... Sheriff,s Office (CCSO) Caldwell, ID has,purchase...Device. CCSO is a,329-man department., Lt. Daren ... product,and was seeking alternatives that would b... these tough times, budget of course is an importa...
...w online magazine dedicated to covering the global...ale.edu . Edited by Roger Cohn, the former editor ...nment 360 aims to become one of the leading Web si...vironmental issues of the day. , The magazine,s i...nmental advocate and author, Bill McKibben; New Yo...
... for scientific know-how than in finding new ways ...ices, an uncertain oil supply, increasing demand f...imate change have made identifying and developing ... , For Biodesign Institute researcher Bruce Ritt... significant opportunity for innovation and fresh ...
Other Biology News:Canyon County Idaho Sheriff's Office to Purchase Stinger S-200s 2Yale Environment 360 magazine launches online 2Biodesign's Rittmann offers promising perspectives on society's energy challenge 2Biodesign's Rittmann offers promising perspectives on society's energy challenge 3
Cassette, Xba I from Takara Mirus Bio
Cassette, Hind III from Takara Mirus Bio
DryStrip aligners from GE Healthcare, formerly Amersham Biosciences
Cassette, Sal I from Takara Mirus Bio
Biology Products: